N-methyl-4-[6-(3-methylazetidin-1-yl)-3-pyridinyl]-5-oxopentanamide

C15H21N3O2 — CID 166112823

IUPACN-methyl-4-[6-(3-methylazetidin-1-yl)-3-pyridinyl]-5-oxopentanamide
SMILESCNC(=O)CCC(C=O)c1ccc(N2CC(C)C2)nc1
InChIInChI=1S/C15H21N3O2/c1-11-8-18(9-11)14-5-3-12(7-17-14)13(10-19)4-6-15(20)16-2/h3,5,7,10-11,13H,4,6,8-9H2,1-2H3,(H,16,20)
InChIKeyCGDKRNJISYMCBC-UHFFFAOYSA-N
MW275.35 g/mol
LogP1.35
Rot. Bonds6

About N-methyl-4-[6-(3-methylazetidin-1-yl)-3-pyridinyl]-5-oxopentanamide

N-methyl-4-[6-(3-methylazetidin-1-yl)-3-pyridinyl]-5-oxopentanamide (PubChem CID 166112823) has the molecular formula C15H21N3O2 and a molecular weight of 275.35 g/mol. Its IUPAC name is N-methyl-4-[6-(3-methylazetidin-1-yl)-3-pyridinyl]-5-oxopentanamide.

Molecular Properties

Compound NameN-methyl-4-[6-(3-methylazetidin-1-yl)-3-pyridinyl]-5-oxopentanamide
PubChem CID166112823
Molecular FormulaC15H21N3O2
Molecular Weight275.35 g/mol
Exact Mass275.16
IUPAC NameN-methyl-4-[6-(3-methylazetidin-1-yl)-3-pyridinyl]-5-oxopentanamide
SMILESCNC(=O)CCC(C=O)c1ccc(N2CC(C)C2)nc1
InChIInChI=1S/C15H21N3O2/c1-11-8-18(9-11)14-5-3-12(7-17-14)13(10-19)4-6-15(20)16-2/h3,5,7,10-11,13H,4,6,8-9H2,1-2H3,(H,16,20)
InChIKeyCGDKRNJISYMCBC-UHFFFAOYSA-N
XLogP1.35
TPSA62.30 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms20
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500275.35
LogP ≤ 51.35
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze N-methyl-4-[6-(3-methylazetidin-1-yl)-3-pyridinyl]-5-oxopentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-[6-(2,6-diazaspiro[3.3]heptan-2-yl)-3-pyridinyl]-N-methyl-5-oxopentanamide
CID 172569732
4-[6-(4-aminopiperidin-1-yl)-3-pyridinyl]-N-formylpentanamide
CID 172586968
4-[[6-(3,5-dimethylpiperidin-1-yl)-3-pyridinyl]amino]-4-oxobutanoic acid
CID 82034786
2-[(3S)-3-methylpyrrolidin-1-yl]-5-propan-2-ylpyridine
CID 121288951
[6-(3,5-dimethylpiperidin-1-yl)-3-pyridinyl]methanol
CID 61257054
1-[5-(1-hydroxyethyl)-2-pyridinyl]-N-methylpiperidine-3-carboxamide
CID 103196725
5-methyl-1-[5-(pentan-3-ylsulfamoyl)-2-pyridinyl]piperidine-3-carboxylic acid
CID 122106763
(2S,6R)-4-(5-butan-2-yl-2-pyridinyl)-2,6-dimethylmorpholine
CID 71155007
methyl 4-(5-propan-2-yl-2-pyridinyl)piperazine-1-carboxylate
CID 165380767
1-[6-(3,5-dimethylpiperidin-1-yl)-3-pyridinyl]-3-propan-2-ylthiourea
CID 133219875
5-(chloromethyl)-2-(3,5-dimethylpiperidin-1-yl)pyridine
CID 61257198
1-(5-formyl-2-pyridinyl)-N-methylpiperidine-4-carboxamide
CID 80637486

Frequently Asked Questions

What is the IUPAC name of N-methyl-4-[6-(3-methylazetidin-1-yl)-3-pyridinyl]-5-oxopentanamide?
The IUPAC name of N-methyl-4-[6-(3-methylazetidin-1-yl)-3-pyridinyl]-5-oxopentanamide (CID 166112823) is N-methyl-4-[6-(3-methylazetidin-1-yl)-3-pyridinyl]-5-oxopentanamide.
What is the SMILES notation for N-methyl-4-[6-(3-methylazetidin-1-yl)-3-pyridinyl]-5-oxopentanamide?
The canonical SMILES for N-methyl-4-[6-(3-methylazetidin-1-yl)-3-pyridinyl]-5-oxopentanamide is CNC(=O)CCC(C=O)c1ccc(N2CC(C)C2)nc1.
What is the InChIKey of N-methyl-4-[6-(3-methylazetidin-1-yl)-3-pyridinyl]-5-oxopentanamide?
The InChIKey is CGDKRNJISYMCBC-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H21N3O2/c1-11-8-18(9-11)14-5-3-12(7-17-14)13(10-19)4-6-15(20)16-2/h3,5,7,10-11,13H,4,6,8-9H2,1-2H3,(H,16,20).
What are the key properties of N-methyl-4-[6-(3-methylazetidin-1-yl)-3-pyridinyl]-5-oxopentanamide?
N-methyl-4-[6-(3-methylazetidin-1-yl)-3-pyridinyl]-5-oxopentanamide has a molecular weight of 275.35 g/mol, XLogP of 1.35, 6 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-methyl-4-[6-(3-methylazetidin-1-yl)-3-pyridinyl]-5-oxopentanamide is sourced from PubChem (CID 166112823), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).